Analysts Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) PT at $4.17

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has earned a consensus recommendation of “Hold” from the five analysts that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $4.1667.

BIOX has been the topic of a number of recent research reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Bioceres Crop Solutions in a research report on Wednesday, October 8th. Wall Street Zen lowered Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, September 13th. Brookline Capital Management lowered Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 21st. Canaccord Genuity Group restated a “hold” rating and issued a $2.50 price objective (down previously from $6.50) on shares of Bioceres Crop Solutions in a research report on Wednesday, September 10th. Finally, Lake Street Capital lowered their price objective on Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th.

Institutional Investors Weigh In On Bioceres Crop Solutions

Hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp boosted its position in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE boosted its position in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares in the last quarter. PDT Partners LLC purchased a new stake in Bioceres Crop Solutions in the 1st quarter worth approximately $81,000. Avanza Fonder AB lifted its position in shares of Bioceres Crop Solutions by 62.9% during the 2nd quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock valued at $117,000 after buying an additional 10,099 shares in the last quarter. Finally, Walleye Capital LLC purchased a new position in shares of Bioceres Crop Solutions during the 1st quarter valued at approximately $199,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX opened at $1.86 on Tuesday. The business’s 50 day moving average price is $1.93 and its 200 day moving average price is $3.38. The firm has a market cap of $116.64 million, a P/E ratio of -2.30 and a beta of 0.41. Bioceres Crop Solutions has a 52 week low of $1.20 and a 52 week high of $7.44. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.22.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.